Darif 7.5 Tablet PR
Marketer
Alembic Pharmaceuticals Ltd
Salt Composition
Darifenacin (7.5mg)
Overview Darif 7.5 Tablet PR
Oxybutynin chloride 7.5mg extended-release tablets are an anticholinergic medication employed to manage overactive bladder symptoms. These tablets alleviate urinary frequency, urgency, and incontinence. Dosage and duration should strictly adhere to your physician's instructions. The medication can be ingested with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms, necessitating completion of the prescribed course for optimal results. Common adverse effects may include constipation, headache, dry mouth, urinary tract infection, nausea, and dry nasal passages. Report any persistent or bothersome side effects promptly to your doctor, who can offer strategies for mitigation. Prior to commencing treatment, disclose all current medications and any existing health conditions. Pregnancy or breastfeeding should also be reported to your doctor. This medication is contraindicated in patients with severe hepatic impairment; consult your doctor before use.
Primary Ingredients of Darif 7.5 Tablet PR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Darif 7.5 Tablet PR
Managing the signs and symptoms of overactive bladder
Major Benefits of Darif 7.5 Tablet PR:
Follow your doctor's instructions or the package insert for proper administration. Darif 7.5 Tablet PR can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Darif 7.5 Tablet PR:
- Constipation
- Dryness in mouth
- Headache
- Dry eye
- Nasal dryness
How to use Darif 7.5 Tablet PR:
Follow your doctor's instructions or refer to the product label for usage guidance. Darif 7.5 Tablet PR can be administered with or without food; however, consistent daily timing is recommended.
How Darif 7.5 Tablet PR works:
Darif 7.5mg tablets (PR) are an antimuscarinic agent. Their mechanism of action involves relaxing bladder musculature, thereby reducing urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Darif 7.5 Tablet PR is not known to be safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Darif 7.5 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Darif 7.5 Tablet PR use may pose a risk. Available human data indicates potential transfer to breast milk, possibly harming the infant.
DrivingUNSAFE
Driving may be impaired by Darif 7.5 Tablet PR, which can induce side effects like dizziness, blurry vision, insomnia, or somnolence.
KidneySAFE IF PRESCRIBED
Darif 7.5 Tablet PR poses no safety concerns for individuals with kidney conditions; no dosage alteration is needed. Nevertheless, disclosure of any pre-existing kidney disease to your physician is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Darif 7.5 Tablet PR cautiously. Dosage modification of Darif 7.5 Tablet PR may be necessary. Physician consultation is advised.
What if you forget to take Darif 7.5 Tablet PR :
Should you forget a Darif 7.5 Tablet PR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Darif 7.5 Tablet PR
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |
3,018 People bought this recently